European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Vaginal wall smooth muscle tumors: a systematic review of literature and a case report of vaginal STUMP
Vaginal wall smooth muscle tumors: a systematic review of literature and a case report of vaginal STUMP
DOI: 10.22514/ejgo.2025.001
Efficacy and safety of anti-HER2 therapy in solid tumors except breast cancer: a systematic-review and meta-analysis
Efficacy and safety of anti-HER2 therapy in solid tumors except breast cancer: a systematic-review and meta-analysis
DOI: 10.22514/ejgo.2025.002
Clinical trial of HPV mRNA testing for uterine cervical cancer screening in Kitakyushu city
Clinical trial of HPV mRNA testing for uterine cervical cancer screening in Kitakyushu city
DOI: 10.22514/ejgo.2025.003
Treatment outcomes and survival in morbidly obese women with endometrial cancer
Treatment outcomes and survival in morbidly obese women with endometrial cancer
DOI: 10.22514/ejgo.2025.005
Identification of differential molecular characteristics and key genes between low- and high-grade serous ovarian cancer by bioinformatics analysis
Identification of differential molecular characteristics and key genes between low- and high-grade serous ovarian cancer by bioinformatics analysis
DOI: 10.22514/ejgo.2025.006
Quality of life in patients with cervical cancer and endometrial cancer during adjuvant treatment—similarities and differences useful in personalized care
Quality of life in patients with cervical cancer and endometrial cancer during adjuvant treatment—similarities and differences useful in personalized care
DOI: 10.22514/ejgo.2025.007
Ecliptae Herba extracts suppress cell proliferation and induce cell apoptosis of ovarian cancer cells by inactivating PI3K/AKT signaling pathway
Ecliptae Herba extracts suppress cell proliferation and induce cell apoptosis of ovarian cancer cells by inactivating PI3K/AKT signaling pathway
DOI: 10.22514/ejgo.2025.008
Comparison of neoadjuvant chemotherapy versus primary cytoreductive surgery in stage III–IV epithelial ovarian cancer: a retrospective study
Comparison of neoadjuvant chemotherapy versus primary cytoreductive surgery in stage III–IV epithelial ovarian cancer: a retrospective study
DOI: 10.22514/ejgo.2025.009
Prognostic impact of molecular subgroups in grade 3 endometrioid endometrial carcinoma: a single cohort study in Northern China
Prognostic impact of molecular subgroups in grade 3 endometrioid endometrial carcinoma: a single cohort study in Northern China
DOI: 10.22514/ejgo.2025.010
High expression of PAFAH1B3 promotes the growth as well as motility and inhibits apoptosis of breast cancer cells
High expression of PAFAH1B3 promotes the growth as well as motility and inhibits apoptosis of breast cancer cells
DOI: 10.22514/ejgo.2025.011
Investigating deep learning approaches for cervical cancer diagnosis: a focus on modern image-based models
Investigating deep learning approaches for cervical cancer diagnosis: a focus on modern image-based models
DOI: 10.22514/ejgo.2025.012
SHCBP1 a potential target in ovarian cancer growth and stemness
SHCBP1 a potential target in ovarian cancer growth and stemness
DOI: 10.22514/ejgo.2025.013
Inhibition of PRPF19 impairs oncogenesis, radioresistance and DNA damage repair in cervical cancer
Inhibition of PRPF19 impairs oncogenesis, radioresistance and DNA damage repair in cervical cancer
DOI: 10.22514/ejgo.2025.014
Extremely long survival in a patient with serous ovarian cancer. A case report and review of the literature
Extremely long survival in a patient with serous ovarian cancer. A case report and review of the literature
DOI: 10.22514/ejgo.2025.015
Published Ahead of Print
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
Online publish date: 28 October 2024
DOI: 10.22514/ejgo.2024.110
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endoemtrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.